Our measurement of serum markers of cancer indicated that NSE, CA-125, and CYA 21-1 levels were similar in NSCLC patients with squamous cell carcinoma and adenocarcinoma. This evidence concerns the gene ENO2 and non-small cell lung carcinoma.